BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1096 related articles for article (PubMed ID: 33272323)

  • 1. Neuroinflammation and protein pathology in Parkinson's disease dementia.
    Kouli A; Camacho M; Allinson K; Williams-Gray CH
    Acta Neuropathol Commun; 2020 Dec; 8(1):211. PubMed ID: 33272323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia.
    Bertrand E; Lechowicz W; Szpak GM; Lewandowska E; Dymecki J; Wierzba-Bobrowicz T
    Folia Neuropathol; 2004; 42(3):141-50. PubMed ID: 15535032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients.
    Doorn KJ; Moors T; Drukarch B; van de Berg WDj; Lucassen PJ; van Dam AM
    Acta Neuropathol Commun; 2014 Aug; 2():90. PubMed ID: 25099483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroinflammation is associated with Alzheimer's disease co-pathology in dementia with Lewy bodies.
    Wetering JV; Geut H; Bol JJ; Galis Y; Timmermans E; Twisk JWR; Hepp DH; Morella ML; Pihlstrom L; Lemstra AW; Rozemuller AJM; Jonkman LE; van de Berg WDJ
    Acta Neuropathol Commun; 2024 May; 12(1):73. PubMed ID: 38715119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia.
    Wills J; Jones J; Haggerty T; Duka V; Joyce JN; Sidhu A
    Exp Neurol; 2010 Sep; 225(1):210-8. PubMed ID: 20599975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein.
    Watson MB; Richter F; Lee SK; Gabby L; Wu J; Masliah E; Effros RB; Chesselet MF
    Exp Neurol; 2012 Oct; 237(2):318-34. PubMed ID: 22750327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.
    Walker L; McAleese KE; Thomas AJ; Johnson M; Martin-Ruiz C; Parker C; Colloby SJ; Jellinger K; Attems J
    Acta Neuropathol; 2015 May; 129(5):729-48. PubMed ID: 25758940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse model.
    Lloyd GM; Dhillon JS; Gorion KM; Riffe C; Fromholt SE; Xia Y; Giasson BI; Borchelt DR
    Mol Neurodegener; 2021 Sep; 16(1):63. PubMed ID: 34503546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson's disease.
    Subbarayan MS; Hudson C; Moss LD; Nash KR; Bickford PC
    J Neuroinflammation; 2020 Aug; 17(1):242. PubMed ID: 32799878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between α-synuclein and tau in Parkinson's disease comment on Wills et al.: elevated tauopathy and α-synuclein pathology in postmortem Parkinson's disease brains with and without dementia. Exp Neurol 2010; 225: 210-218.
    Jellinger KA
    Exp Neurol; 2011 Jan; 227(1):13-8. PubMed ID: 20965169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson's disease pathogenesis.
    Hughes CD; Choi ML; Ryten M; Hopkins L; Drews A; Botía JA; Iljina M; Rodrigues M; Gagliano SA; Gandhi S; Bryant C; Klenerman D
    Acta Neuropathol; 2019 Jan; 137(1):103-120. PubMed ID: 30225556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease.
    Kalaitzakis ME; Christian LM; Moran LB; Graeber MB; Pearce RK; Gentleman SM
    Parkinsonism Relat Disord; 2009 Mar; 15(3):196-204. PubMed ID: 18602855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grey matter volume correlates of cerebrospinal markers of Alzheimer-pathology in Parkinson's disease and related dementia.
    Compta Y; Ibarretxe-Bilbao N; Pereira JB; Junqué C; Bargalló N; Tolosa E; Valldeoriola F; Muñoz E; Camara A; Buongiorno M; Martí MJ
    Parkinsonism Relat Disord; 2012 Sep; 18(8):941-7. PubMed ID: 22595621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusions.
    Stoyka LE; Arrant AE; Thrasher DR; Russell DL; Freire J; Mahoney CL; Narayanan A; Dib AG; Standaert DG; Volpicelli-Daley LA
    Neurobiol Dis; 2020 Feb; 134():104708. PubMed ID: 31837424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson's and Alzheimer's diseases.
    Hannula MJ; Myöhänen TT; Tenorio-Laranga J; Männistö PT; Garcia-Horsman JA
    Neuroscience; 2013 Jul; 242():140-50. PubMed ID: 23562579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology.
    Dzamko N; Gysbers A; Perera G; Bahar A; Shankar A; Gao J; Fu Y; Halliday GM
    Acta Neuropathol; 2017 Feb; 133(2):303-319. PubMed ID: 27888296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of pathological markers in Parkinson's disease dementia post-mortem brains compared to dementia with Lewy bodies.
    Tu H; Zhang ZW; Qiu L; Lin Y; Jiang M; Chia SY; Wei Y; Ng ASL; Reynolds R; Tan EK; Zeng L
    BMC Neurosci; 2022 Jan; 23(1):3. PubMed ID: 34983390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease.
    Galiano-Landeira J; Torra A; Vila M; Bové J
    Brain; 2020 Dec; 143(12):3717-3733. PubMed ID: 33118032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases.
    Duka V; Lee JH; Credle J; Wills J; Oaks A; Smolinsky C; Shah K; Mash DC; Masliah E; Sidhu A
    PLoS One; 2013; 8(9):e75025. PubMed ID: 24073234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disturbed sleep in Parkinson's disease: anatomical and pathological correlates.
    Kalaitzakis ME; Gentleman SM; Pearce RK
    Neuropathol Appl Neurobiol; 2013 Oct; 39(6):644-53. PubMed ID: 23363035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.